home - exercise program for Multiple Sclerosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Arkansas for Medical Sciences, Little Rock, AR
Multiple Sclerosis+2 More
home - exercise program - Other
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This research study plans to evaluate if multifidus muscle dysfunction is associated with back pain in patients with Multiple Sclerosis (MS).

Eligible Conditions

  • Multiple Sclerosis
  • Back Pain

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Multiple Sclerosis

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 6 months

6 months
Evaluate the relation between compliance with the home-exercise program and the change in the cross-section area of the multifidus muscle and the change in pain score using PROMIS scale
qualify the multifidus dysfunction in patients with MS - physical exam
qualify the multifidus dysfunction in patients with MS - ultrasound
study the compliance of a home-exercise program in patients with MS

Trial Safety

Safety Progress

1 of 3

Other trials for Multiple Sclerosis

Trial Design

1 Treatment Group

Intervention group
1 of 1
Experimental Treatment

10 Total Participants · 1 Treatment Group

Primary Treatment: home - exercise program · No Placebo Group · Phase < 1

Intervention group
Other
Experimental Group · 1 Intervention: home - exercise program · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Closest Location: University of Arkansas for Medical Sciences · Little Rock, AR
Photo of Little Rock 1Photo of Little Rock 2Photo of Little Rock 3
2011First Recorded Clinical Trial
3 TrialsResearching Multiple Sclerosis
445 CompletedClinical Trials

Who is running the clinical trial?

University of ArkansasLead Sponsor
455 Previous Clinical Trials
139,829 Total Patients Enrolled
Erika Santos Horta, MDPrincipal InvestigatorUniversity of Arkansas

Eligibility Criteria

Age 18 - 65 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.